Key Sun Pharma drugs to bid Halol goodbye

Halol plant is key for Sun Pharma and contributed in high single digits to its US sales

Sun Pharmaceutical Industries plans to shift production of key products from its Halol (Gujarat) factory to other facilities, following a weak December quarter which saw nearly five per cent drop in net profit.

Halol is important for the company and contributed in high single digits to its US sales before it was issued a warning letter from the regulator there in December 2015. No new products have been approved from the plant by the US Food and Drug Administration since September 2014.

The regulatory action and consequent remedial measures has resulted in disruption of supply from the plant